My understanding is their have only been 3 production runs maybe 4 now. So having one tube from every batch isn't unrealistic.
As for the differences between batches, well the facility was TGA approved and QA tested. So although the company has communicated in announcements that they have difficulties obtaining the active ingredient and issues with stability, the end product would still fall within a fairly specific boundary. I wouldn't expect any noticable difference in effectiveness.
Chemists stocking our brand is now beyond our control. Let's concentrate on what is within our control...getting 2 more products out there to take pressure off Thermalife.
- Forums
- ASX - By Stock
- CAI
- management
management, page-26
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAI (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.67M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
CAI (ASX) Chart |
Day chart unavailable